\begin{center}
\begin{tabular}{ p{4cm} p{4cm} p{4cm} p{2cm} }
\toprule
\multicolumn{2}{ c }{Independent variables (factors)} & Value of the coefficient & p-value\\
\cmidrule(lr){1-2}\cmidrule(lr){3-4}
\multirow{ 2}{*}{ \textit{Signal quality} } & \gls{eog} correction & $-0.081$ & $0.40$\\ 
& \textbf{artifact correction based on amplitude} & \hspace{0.2cm} $0.15$ & $ 0.039$\\ 
\cmidrule(lr){1-2}\cmidrule(lr){3-4}
\multirow{ 3}{*}{ \textit{Methodological} } & \textbf{\gls{pblind}} & \hspace{0.2cm} $0.11$ & $0.038$\\ 
& randomization & \hspace{0.2cm} $0.0099$ & $0.89$\\ 
& \textbf{\gls{irb}} & $-0.30$ & $0.00$\\ 
\cmidrule(lr){1-2}\cmidrule(lr){3-4}
\multirow{ 3}{*}{ \textit{Population} } & age max & $-0.087$ & $0.17$\\
& age min & $-0.050$ & $0.43$\\
& on drugs & \hspace{0.2cm} $0.065$ & $0.45$\\
\cmidrule(lr){1-2}\cmidrule(lr){3-4}
\multirow{ 9}{*}{ \textit{\gls{nfb} implementation} } & number of sessions  & $-0.015$ & $0.84$\\
& session length & \hspace{0.2cm} $0.17$ & $0.18$\\
& \textbf{session pace} & $-0.25$ & $0.00$\\ 
& \textbf{treatment length} & \hspace{0.2cm} $0.57$ & $0.00$\\
& \gls{smr} & $-0.067$ & $0.38$\\ 
& beta up central & $-0.025$ & $0.73$\\  
& \textbf{theta down} & $-0.29$ & $0.019$\\
& \gls{scp} & $-0.90$ & $0.54$\\
& \textbf{transfer phase} & \hspace{0.2cm} $0.27$ & $0.030$\\
\cmidrule(lr){1-2}\cmidrule(lr){3-4}
\multirow{ 2}{*}{ \textit{Quality of acquisition} } & more than one active electrode & \hspace{0.2cm} $0.0639$ & $0.359$\\ 
& \textbf{\gls{eeg} quality 2} & $-0.36$ & $0.00$\\ 
\bottomrule
\end{tabular}
\end{center}